Triple-negative breast cancer is defined by the cancer’s lack of three receptors - estrogen, progesterone, and HER2. This recording discusses research to identify targets and develop new therapies, as well as the treatments in use today. Hear how you can impact change by taking part in clinical trials, and gain strategies to manage side effects and improve your quality of life.